How to Tell If a Mole Is Cancerous: Warning Signs

A mole that is asymmetric, has an irregular border, shows multiple colors, measures larger than about 6 millimeters across, or is visibly evolving over time meets one or more of the classic warning signs for melanoma. These five features form the well-known ABCDE checklist that dermatologists have used for decades. But the checklist is just a starting point, and the full picture of what makes a mole suspicious is more nuanced than any single acronym captures.

The ABCDE Checklist in Practice

The letters stand for Asymmetry, Border irregularity, Color variation, Diameter greater than 6 mm, and Evolving appearance. Each feature on its own raises your level of concern a notch; the more features a mole hits, the more urgently it should be evaluated. In real life, the most actionable of these is the “E” for evolving. A mole that looked one way six months ago and looks different now, whether it changed in size, shape, color, or started itching, bleeding, or crusting, deserves professional attention regardless of what the other letters say.

Visual inspection using criteria like ABCDE is the foundation of melanoma detection, but its accuracy varies depending on the setting. A large Cochrane review encompassing over 34,000 lesions found that when clinicians assessed lesions with limited prior testing, sensitivity was about 92% but specificity was around 80%, meaning many benign moles get flagged. When the evaluation happened among lesions already referred for specialist assessment, sensitivity dropped to roughly 77% while specificity climbed to about 96%.¹ That same review found no clear evidence that using any particular algorithm, including ABCDE, consistently improved accuracy across all clinical settings. The checklist helps, but it is not a precision instrument.

The Ugly Duckling Sign

Most of your moles share a family resemblance. They tend to be roughly the same size, shape, and color as one another. The ugly duckling sign asks you to identify the mole that breaks the pattern, the one that looks nothing like its neighbors. A dark brown, irregular mole surrounded by small, round, light brown moles stands out. So does a tiny pinkish bump on someone whose other moles are all flat and dark. The concept is simple: the outlier is the one worth checking.

Researchers have proposed combining the ugly duckling approach with the traditional ABCDE criteria into what they call the ABCDEF rule, where “F” stands for “funny-looking” or the outlier mole. The rationale is that some melanomas satisfy just one or two ABCDE features and might not seem worrying on their own. But when those same lesions are clearly the odd one out among a person’s other moles, the combination flags them more reliably.² If you are doing a self-check at home, looking for the mole that does not fit in is one of the most practical things you can do, especially if you have many moles.

When Melanoma Doesn’t Look Like a Mole

The ABCDE criteria were designed around the most common form of melanoma: a dark, irregularly pigmented flat or slightly raised lesion. The trouble is that not every melanoma plays by those rules. Nodular melanoma, for instance, often appears as a firm, dome-shaped bump that can grow quickly. Patients who noticed their own nodular melanomas have described early features like a small raised spot, sometimes with white coloring and very small diameter, neither of which fits neatly into the classic criteria.³ For nodular melanoma, the acronym EFG (elevated, firm, growing) was developed as a supplement to ABCDE, capturing lesions that are more lump than stain.

Amelanotic melanoma is an even trickier blind spot. These melanomas lack the dark pigment most people associate with skin cancer and instead present as pink, red, or skin-colored spots. In one study examining red amelanotic melanomas, clinicians included melanoma in their initial list of possible diagnoses only about 32% of the time, compared with 94% for pigmented melanomas. The majority of those who missed the diagnosis were dermatologists, not just general practitioners.⁴ The most common alternative diagnoses were basal cell carcinoma and benign conditions like dermatofibroma or eczema. If even trained dermatologists can be fooled, you should not assume a non-pigmented spot is harmless just because it does not look like a “typical” mole.

Melanoma on Palms, Soles, and Nails

Acral lentiginous melanoma occurs on the hairless skin of the palms, soles, and under fingernails or toenails. It is the least common subtype of cutaneous melanoma overall, but it is disproportionately represented in people with darker skin tones because the more common sun-related subtypes are rarer in those populations.⁵ Under a nail, it often shows up as a dark streak running lengthwise, sometimes accompanied by darkening of the surrounding skin fold. On the sole of the foot, it can look like a bruise or discolored patch that doesn’t heal.

Acral lentiginous melanoma tends to be diagnosed at more advanced stages and carries a worse prognosis compared to other melanoma subtypes, partly because patients and doctors are not looking for cancer in those locations.⁶ A dark line on a nail that is new, widening, or affecting the skin around the nail deserves a visit to a dermatologist. The same goes for any non-healing sore or dark patch on the palm or sole, especially if it appeared without trauma.

How Children’s Melanomas Present Differently

Melanoma in children is rare, but when it does occur, it often sidesteps the adult ABCDE criteria entirely. A study of a large cohort of pediatric melanoma cases found that 60% of children under 10 and 40% of those between 11 and 19 did not present with conventional ABCDE features. Instead, the most common warning signs were amelanosis (lack of pigment), bleeding or bumps, uniform color rather than color variation, variable or small diameter, and the lesion arising de novo rather than from an existing mole.⁷ In other words, the classic “dark, irregular, large” profile that adults and their doctors are trained to spot may actually mislead parents into dismissing a child’s suspicious lesion because it does not look like the pictures they have seen. A pink or flesh-colored bump on a child that bleeds easily or keeps growing should prompt evaluation, even if it looks nothing like a textbook melanoma.

Risk Factors That Should Lower Your Threshold

Some people need to be more vigilant than others, and knowing your personal risk profile helps calibrate how seriously to take a changing mole. Having many moles is one of the strongest risk factors. One study found that individuals who carried both a high mole count (20 or more that were at least 5 mm) and specific red-hair-associated gene variants had an odds ratio for melanoma above 25 compared to people with fewer moles and no such gene variants.⁸ You do not need to know your exact genotype for this to matter practically: if you have fair skin, red or blond hair, a lot of moles, and a tendency to burn rather than tan, you are in a higher-risk group where even subtle changes in a mole deserve attention.

Sunburn history is another major factor, and the risk is not limited to childhood burns the way many people believe. A comprehensive meta-analysis showed that increasing numbers of sunburns raised melanoma risk across all periods of life, including adulthood, not just childhood or adolescence.⁹ When the rates were converted to comparable time frames, adult and lifetime sunburns per decade actually carried the highest risk. A separate large cohort study of Norwegian women found that those with a consistently high pattern of sunburn over their lifetimes had about a 50% higher melanoma risk compared to those with stable low sunburn histories.¹⁰ And a Mendelian randomization study, which uses genetic data to test for causal relationships, found evidence that childhood sunburn does have a causal link to later melanoma risk.¹¹ The upshot: sunburn at any age matters, and if you have accumulated many burns over your lifetime, you should be especially attentive to new or changing moles.

What Happens at the Doctor’s Office

When you bring a suspicious mole to a dermatologist, the first step is usually dermoscopy, a handheld magnifying device with polarized light that lets the clinician see structures within the skin that are invisible to the naked eye. A Cochrane review found that dermoscopy is significantly more accurate than visual inspection alone for diagnosing melanoma.¹² A scoping review confirmed that dermoscopy improves the accuracy of skin cancer diagnosis across dermatology settings.¹³ Under dermoscopy, clinicians look for specific patterns: irregular networks of pigment, blue-white veils, atypical blood vessel patterns, regression structures. A study examining lesions that showed a blue-white veil, a feature sometimes seen in both seborrheic keratoses and melanoma, found that certain combinations of sub-features could reliably distinguish benign from malignant lesions.¹⁴

If the dermoscopic exam raises concern, the next step is a biopsy. There are different techniques: shave biopsies take a thin slice, punch biopsies take a small cylindrical core, and excisional biopsies remove the entire lesion. One large study found that shave biopsy provided accurate diagnostic data in about 97% of melanoma cases, challenging the longstanding belief that only full-thickness excision gives reliable results.¹⁵ A systematic review and meta-analysis did find that punch biopsies were associated with a somewhat higher rate of all-cause mortality compared to other methods, though the differences in melanoma-specific outcomes were not statistically significant.¹⁶ In practice, your dermatologist will choose a technique based on the lesion’s size, location, and level of suspicion, and the most important thing is that the biopsy happens rather than that you worry about which method is used.

Smartphone Apps and AI-Assisted Detection

Several smartphone apps now use artificial intelligence to assess skin lesions from photos. The idea is appealing: snap a picture, get a risk rating, decide whether to see a doctor. But the evidence so far suggests caution. A systematic review of algorithm-based smartphone apps found that one of the most studied, SkinVision, achieved about 80% sensitivity and 78% specificity for detecting malignant or premalignant lesions, and its accuracy when verified against expert recommendations was poor.¹⁷

More recent data from a prospective study of a deep-learning-based app found that the AI achieved about 83% sensitivity and 77% specificity for skin cancer detection. Adding remote dermatologist review on top of the AI improved specificity to about 87%, but at the cost of some sensitivity. The app’s sensitivity was lower for melanocytic lesions, the very category that includes melanoma, than for non-melanocytic cancers.¹⁸ A population-level study in Sweden found that people using one such app were more likely to have malignant lesions detected compared to the general population, which sounds promising. But they were also almost four times more likely to have claims for benign lesions, meaning the app drove a substantial amount of unnecessary medical attention.¹⁹ These tools can be a reasonable nudge to go see a doctor when you are on the fence, but they should not be used to rule out melanoma. A “low risk” reading from an app does not replace a dermatologist’s evaluation.

Why People Wait Too Long

Knowing the warning signs is only useful if you act on them, and a surprising number of people do not. Qualitative research has shown that the journey from noticing a change to actually booking an appointment is often slow and winding. People tend to compare a suspicious lesion against their own “normal” moles, or against moles on family members or images they have seen, and only take action when the comparison becomes alarming enough, typically when the lesion has grown substantially. Pain, itching, or bleeding often serve as the trigger that finally tips someone from “I should keep an eye on it” into actually calling a doctor.²⁰

Research on patient-caused delay in melanoma diagnosis found that general knowledge about melanoma was poor in many patients, particularly among men, and that wrong beliefs about what melanoma looks like were widespread. Both negligence and anxiety contributed to longer delays, with the anxious pattern being less intuitive: some patients who were worried about what a mole might be actively avoided getting it checked because they feared the answer.²¹ If you recognize that impulse in yourself, it is worth remembering that earlier detection nearly always means simpler treatment and better outcomes. Melanoma caught while still thin and localized is overwhelmingly survivable; melanoma that has had time to thicken and spread is far more dangerous.

Skin Self-Examination Actually Works

Regular, thorough self-examination of your skin is one of the most effective things you can do, especially if you are in a higher-risk group. A randomized trial found that structured skin self-examination training, where patients and their partners were taught how to check each other systematically, led to significantly earlier detection of new melanomas. Trained pairs identified 43 melanomas, including 33 stage 0 melanomas (the earliest, most treatable stage), while untrained control pairs identified none on their own. Physicians caught 10 additional melanomas in the intervention group, several of which were in locations the patient could not see without a partner’s help.²² Another randomized trial of thorough skin self-examination training suggested long-term benefit for early melanoma detection with only a short-term increase in unnecessary skin surgeries.²³

The practical takeaway is that self-checks work best when they are routine and partnered. Once a month, check your entire body including the scalp, between toes, under nails, and on the soles of your feet. Have a partner examine your back and other hard-to-see areas. Photograph moles you want to track so you have a baseline for comparison. You are not trying to diagnose yourself; you are trying to notice change early enough that a doctor can catch melanoma when it is still straightforward to treat.

Why Melanoma Detection Is Harder on Darker Skin

Most melanoma education materials, training datasets, and clinical images overwhelmingly feature fair-skinned individuals. This creates a detection gap on two levels. First, patients with darker skin may not recognize the visual cues described in standard awareness campaigns because those campaigns rarely show what melanoma looks like on brown or black skin. Second, AI tools trained on datasets skewed toward lighter skin perform worse on darker skin tones. Researchers have found that generating synthetic images of skin lesions on diverse skin colors and adding them to training data significantly improves classification accuracy, from about 56% without the diverse images to about 76% with them.²⁴ Dermatologists shown the synthetic images could correctly diagnose the depicted lesions about 75% of the time, suggesting the generated images were clinically realistic.

For people with darker skin, acral sites like the palms, soles, and nail beds deserve particular attention, since acral lentiginous melanoma is proportionally more common in these populations. Melanoma can also develop in the mucous membranes (inside the mouth or nose) and in areas not typically exposed to the sun. A dark streak appearing on a nail, any non-healing sore on the sole of the foot, or a new patch of discoloration inside the mouth should all prompt a medical visit, regardless of how low your overall statistical risk of melanoma might be.

What Happens Inside a Mole That Turns Cancerous

Most moles start with a mutation in a single growth-promoting gene that causes pigment-producing cells to multiply and form a cluster. That cluster is a benign nevus, an ordinary mole. Several built-in braking systems prevent those cells from multiplying further. For a mole to become melanoma, additional genetic changes have to override those brakes.²⁵ One of the most commonly mutated genes in melanoma is BRAF, which is altered in a large fraction of cases and leads to uncontrolled activation of a key growth signaling pathway.²⁶ This matters practically because BRAF-targeted therapies now exist and have changed the treatment landscape for advanced melanoma, but at the detection stage, the key point is that a mole sitting quietly on your skin has already passed through one gate on the road to cancer. The difference between that stable mole and one that turns dangerous lies in whether additional mutations accumulate over time, something ultraviolet radiation, among other factors, promotes.